A novel BCL-2/BCL-Xl dual inhibitor overcomes ibrutinib-resistance conferred by the upregulation of integrin pathway and BCL-Xl
Home » A novel BCL-2/BCL-Xl dual inhibitor overcomes ibrutinib-resistance conferred by the upregulation of integrin pathway and BCL-Xl
November 13, 2019
Deng J, Mao T, Huang X, et al. A novel BCL-2/BCL-Xl dual inhibitor overcomes ibrutinib-resistance conferred by the upregulation of integrin pathway and BCL-Xl. Blood 2019;134(Supplement 1): 2573. vol. Abstract 2573, View